Integra LifeSciences Holdings Corporation
IART
$17.42
$0.352.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 418.76M | 391.92M | 434.93M | 402.06M | 415.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 418.76M | 391.92M | 434.93M | 402.06M | 415.61M |
| Cost of Revenue | 185.09M | 163.50M | 189.79M | 172.23M | 186.41M |
| Gross Profit | 233.67M | 228.42M | 245.13M | 229.84M | 229.19M |
| SG&A Expenses | 167.22M | 165.16M | 167.92M | 166.94M | 171.06M |
| Depreciation & Amortization | 3.77M | 3.78M | 3.77M | 3.73M | 3.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 378.47M | 351.13M | 380.82M | 362.17M | 382.93M |
| Operating Income | 40.29M | 40.79M | 54.10M | 39.89M | 32.67M |
| Income Before Tax | 4.74M | -2.41M | 4.31M | -6.82M | -530.95M |
| Income Tax Expenses | 262.00K | 2.21M | 6.01M | -1.42M | -46.88M |
| Earnings from Continuing Operations | 4.48M | -4.62M | -1.70M | -5.40M | -484.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.48M | -4.62M | -1.70M | -5.40M | -484.07M |
| EBIT | 40.29M | 40.79M | 54.10M | 39.89M | 32.67M |
| EBITDA | 78.43M | 79.22M | 92.53M | 78.41M | 70.37M |
| EPS Basic | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 |
| Normalized Basic EPS | 0.22 | 0.23 | 0.28 | 0.18 | 0.13 |
| EPS Diluted | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 |
| Normalized Diluted EPS | 0.22 | 0.23 | 0.28 | 0.18 | 0.13 |
| Average Basic Shares Outstanding | 77.29M | 76.95M | 76.78M | 76.75M | 76.70M |
| Average Diluted Shares Outstanding | 78.17M | 76.95M | 76.78M | 76.75M | 76.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |